Core Viewpoint - The company is actively exploring technological improvements in synthetic biology applications for pharmaceutical intermediates and active pharmaceutical ingredients to reduce production costs and environmental pollution [2] Group 1 - The company is focusing on technological exploration in synthetic biology [2] - The aim is to lower production costs [2] - The initiative also targets the reduction of environmental pollution [2]